what is a compounded semaglutide (GLP-1) Compounded semaglutide vs. Ozempic
Description
Treatment with GLP-1RA or SGLT2-I was defined as at least three dispensations of the medication

This was based largely on the FLOW trial, which found that patients with CKD and Type 2 diabetes who took semaglutide had a significantly lower risk of major kidney events (kidney failure, dialysis, transplant)

Brown adipose tissue and its therapeutic potential

Where would the GLP-1s fit

Rapid Onset Post Meal Management: Starts targeting circulating blood sugar profiles within fifteen minutes of administration to smoothly counter postprandial glycemic elevations

Research supports a reduction in major cardiovascular events in adults with type 2 diabetes